William D. Haydon - Mar 6, 2023 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, GM Pain Franchise
Signature
/s/ Mojirade James, as attorney-in-fact for William D. Haydon
Stock symbol
AVNS
Transactions as of
Mar 6, 2023
Transactions value $
-$44,815
Form type
4
Date filed
3/7/2023, 03:42 PM
Previous filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability -$44.8K -1.51K -5.05% $29.62 28.4K Mar 6, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
F2 Total beneficially owned includes 140 shares acquired on December 30, 2022 and 595 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.